158. Tuberous sclerosis Clinical trials / Disease details
Clinical trials : 112 / Drugs : 71 - (DrugBank : 19) / Drug target genes : 35 - Drug target pathways : 118
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02104011 (ClinicalTrials.gov) | May 22, 2015 | 1/4/2014 | Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers | Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers: Pilot Trial | Renal Angiomyolipomas;Tuberous Sclerosis | Drug: Propranolol | University Hospital, Bordeaux | NULL | Completed | 18 Years | N/A | All | 2 | Phase 2 | France |